Brooks Laboratories gains on completing expansion at its Baddi unit in Himachal Pradesh

01 Apr 2016 Evaluate

Brooks Laboratories is currently trading at Rs. 86.60, up by 0.65 points or 0.76% from its previous closing of Rs. 85.95 on the BSE.

The scrip opened at Rs. 88.90 and has touched a high and low of Rs. 88.90 and Rs. 86.00 respectively. So far 2661 shares were traded on the counter.

The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 124.15 on 12-Jan-2016 and a 52 week low of Rs. 39.50 on 01-Apr-2015.

Last one week high and low of the scrip stood at Rs. 93.00 and Rs. 79.50 respectively. The current market cap of the company is Rs. 139.12 crore.

The promoters holding in the company stood at 60.62% while Institutions and Non-Institutions held 0.01% and 39.37% respectively.

Brooks Laboratories has completed expansion at its Baddi unit in Himachal Pradesh. Further, certain regulatory approvals are still awaited at its Vadodara Unit in the Gujarat state and it is expected that commercial production will commence within next six months. 

Brooks Laboratories is a Research and Development driven Pharmaceutical manufacturing company, in last 6 years company has successfully established itself as a reputed Contract Manufacturing company for latest molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Brooks Laboratories Share Price

165.50 3.20 (1.97%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.